Mical Paul

1997–2025 年に発表

182
論文数
31,208
被引用数
94
h 指数
172
i10 指数

被引用数

Mical Paul の年別被引用数1965 年: 被引用 2 件1977 年: 被引用 1 件1980 年: 被引用 1 件1986 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 1 件1998 年: 被引用 2 件1999 年: 被引用 3 件2000 年: 被引用 4 件2001 年: 被引用 4 件2002 年: 被引用 4 件2003 年: 被引用 7 件2004 年: 被引用 11 件2005 年: 被引用 25 件2006 年: 被引用 33 件2007 年: 被引用 55 件2008 年: 被引用 69 件2009 年: 被引用 67 件2010 年: 被引用 96 件2011 年: 被引用 148 件2012 年: 被引用 140 件2013 年: 被引用 171 件2014 年: 被引用 182 件2015 年: 被引用 159 件2016 年: 被引用 168 件2017 年: 被引用 208 件2018 年: 被引用 250 件2019 年: 被引用 992 件2020 年: 被引用 1,190 件2021 年: 被引用 1,296 件2022 年: 被引用 1,220 件2023 年: 被引用 1,001 件2024 年: 被引用 1,684 件2025 年: 被引用 731 件2026 年: 被引用 12 件1966〜1976 年は被引用が無いため表示していません1978〜1979 年は被引用が無いため表示していません1981〜1985 年は被引用が無いため表示していません1987〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,406 件、この内訳の 16.3%中国: 引用元論文 1,283 件、この内訳の 8.7%イギリス: 引用元論文 1,003 件、この内訳の 6.8%イタリア: 引用元論文 767 件、この内訳の 5.2%ドイツ: 引用元論文 656 件、この内訳の 4.5%スペイン: 引用元論文 640 件、この内訳の 4.3%フランス: 引用元論文 618 件、この内訳の 4.2%オーストラリア: 引用元論文 525 件、この内訳の 3.6%カナダ: 引用元論文 462 件、この内訳の 3.1%インド: 引用元論文 388 件、この内訳の 2.6%スイス: 引用元論文 371 件、この内訳の 2.5%オランダ: 引用元論文 352 件、この内訳の 2.4%
0%16.3%その他 35.8%

分野

  • Medicine40%
  • Biochemistry, Genetics and Molecular Biology37%
  • Immunology and Microbiology8.9%
  • Environmental Science3.9%
  • Agricultural and Biological Sciences3%
  • Health Professions1.3%
  • その他5.9%

トピック

  • Antibiotic Resistance in Bacteria12.8%
  • Antibiotics Pharmacokinetics and Efficacy5.4%
  • Antibiotic Use and Resistance5.3%
  • Bacterial Identification and Susceptibility Testing3.3%
  • Nosocomial Infections in ICU2.6%
  • Pneumonia and Respiratory Infections2.5%
  • その他68.1%

共著者

全論文

検索で開く
  1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oliver J. Dyar, Alex W. Friedrich, Ana Cristina Gales, Sumanth Gandra, Christian G. Giske, Debra A. Goff, Herman Goossens, Thomas Gottlieb, Manuel Guzmán Blanco, Waleria Hryniewicz, Deepthi Kattula, Timothy Jinks, Souha S. Kanj, Lawrence D. Kerr, Marie-Paule Kiény, Yang Soo Kim, Roman S. Kozlov, Jaime Labarca, Ramanan Laxminarayan, Karin Leder, Leonard Leibovici, Gabriel Levy-Hara, Jasper Littman, Surbhi Malhotra‐Kumar, Vikas Manchanda, Lorenzo Moja, B Ndoye, Angelo Pan, David L. Paterson, Mical Paul, Haibo Qiu, Pilar Ramón-Pardo, Jesús Rodríguez‐Baño, Maurizio Sanguinetti, Sharmila Sengupta, Mike Sharland, Massinissa Si-Mehand, Lynn L. Silver, Wonkeung Song, Martin Steinbakk, Jens Thomsen, Guy Thwaites, J W van der Meer, Nguyễn Văn Kính, Silvio Vega, María Virginia Villegas, Agnes Wechsler-Fördös, Heiman Wertheim, Evelyn Wesangula, Neil Woodford, Fidan O Yilmaz, Anna Zorzet - The Lancet Infectious Diseases 2017 被引用: 6,087

  2. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

    著者: , , , , , , , , , , , , , , , , , , , , - Clinical Microbiology and Infection 2021 被引用: 995

  3. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)

    著者: , , , , , , , , , , , , , , , , , - Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2019 被引用: 931

  4. Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed

    著者: , , , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2022 被引用: 239

  5. Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 被引用: 624

  6. Critical analysis of antibacterial agents in clinical development

    著者: , , , , , , - Nature Reviews Microbiology 2020 被引用: 372

  7. Comparison of antibiotic-resistant bacteria and antibiotic resistance genes abundance in hospital and community wastewater: A systematic review

    著者: , , , , , , , , , - The Science of The Total Environment 2020 被引用: 290

  8. Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naomi Runnegar, David Andresen, Nicholas Anagnostou, Sandra Johnson, Mark D. Chatfield, Allen Cheng, Vance G. Fowler, Benjamin P. Howden, Niamh Meagher, David J. Price, Sebastiaan J. van Hal, Matthew O’Sullivan, Joshua S. Davis - JAMA 2020 被引用: 275

  9. Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jason M. Pogue - NEJM Evidence 2022 被引用: 143

  10. Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2018 被引用: 412

  11. Cefiderocol for the Treatment of Infections Due to Metallo-B-lactamase–Producing Pathogens in the CREDIBLE-CR and APEKS-NP Phase 3 Randomized Studies

    著者: , , , , , , - Clinical Infectious Diseases 2022 被引用: 105

  12. Corticosteroids for pneumonia

    著者: , , , , , - Cochrane Database of Systematic Reviews 2017 被引用: 272

  13. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , P. Höger, Xiaoyun Hu, Quazi Tarikul Islam, Mirela Foresti Jiménez, Amr Kandeel, Gerben Keijzers, Hossein Khalili, Marian Knight, Koichiro Kudo, Gabriela Kusznierz, Ilija Kuzman, Arthur Ming‐Chit Kwan, Idriss Lahlou Amine, Eduard Langenegger, Kamran Bagheri Lankarani, Yee‐Sin Leo, Rita Linko, Pei Liu, Faris Madanat, Elga Mayo-Montero, Allison McGeer, Ziad A. Memish, Gökhan Metan, Auksė Mickienė, Dragan Mikić, Kristin G. I. Mohn, Ahmadreza Moradi, Pagbajabyn Nymadawa, Maria E. Oliva, Mehpare Özkan, Dhruv Parekh, Mical Paul, Fernando P. Polack, Barbara A. Rath, Alejandro Rodríguez, Elena Beatriz Sarrouf, Anna C. Seale, Bünyamin Sertoğullarından, Marilda Mendonça Siqueira, Joanna Skręt‐Magierło, Stephan Frank, Ewa Talarek, Julian W. Tang, Kelvin Kai‐Wang To, Antoni Torres, Selda Hançerlı Törün, Dat Tran, Timothy M. Uyeki, Annelies van Zwol, Wendy Vaudry, Tjasa Vidmar, Renata T C Yokota, Paul Zarogoulidis, Jonathan S. Nguyen‐Van‐Tam - The Lancet Respiratory Medicine 2014 被引用: 648

  14. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients

    著者: , , , , - Cochrane Database of Systematic Reviews 2014 被引用: 451

  15. Systematic Review and Meta-Analysis of the Efficacy of Appropriate Empiric Antibiotic Therapy for Sepsis

    著者: , , , , , - Antimicrobial Agents and Chemotherapy 2010 被引用: 724

  16. Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis

    著者: , , , , , , , , , , , , , - Clinical Microbiology and Infection 2021 被引用: 104

  17. Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2024 被引用: 102

  18. Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis

    著者: , , , , , , , , - Trials 2022 被引用: 119

  19. TheStaphylococcus aureusNetwork Adaptive Platform Trial Protocol: New Tools for an Old Foe

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emma Best, Max Bloomfield, Jennifer Bostock, Carly L. Botheras, Asha C Bowen, Philip N Britton, Hannah J. Burden, Anita J Campbell, Hannah Carter, Matthew P. Cheng, Ka Lip Chew, Russel Lee Ming Chong, Geoffrey W. Coombs, Peter Daley, Nick Daneman, Jane C. Davies, Joshua S. Davis, Yael Dishon, Ravindra Dotel, Adrian Dunlop, Felicity Flack, Katie L. Flanagan, Hong Foo, Nesrin Ghanem‐Zoubi, Stefano Giulieri, Anna L. Goodman, Jennifer Grant, Dan Gregson, Stephen Guy, Amanda Gwee, Erica Hardy, Andrew Henderson, George Heriot, Benjamin P. Howden, Fleur Hudson, Jennie Johnstone, Shirin Kalimuddin, Dana de Kretser, Andrea Lay‐Hoon Kwa, Todd A. Lee, Amy Legg, Roger Lewis, Martin Llewelyn, Thomas Lumley, David Chien Lye, Derek R. MacFadden, Robert K. Mahar, Isabelle Malhamé, Michael Marks, Julie Marsh, Marianne Martinello, Gail Matthews, Colin McArthur, Anna McGlothlin, Genevieve McKew, Brendan McMullan, Zoe McQuilten, Eliza Milliken, Jocelyn Mora, Susan C. Morpeth, Srinivas Murthy, Clare Nourse, Matthew O’Sullivan, David L. Paterson, Mical Paul, Neta Petersiel, Lina Petrella, Sarah Pett, David J. Price, Jason Roberts ほか 27 名 - Clinical Infectious Diseases 2022 被引用: 101

  20. Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals

    著者: , , , , , - Microbial Pathogenesis 2012 被引用: 426

  21. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis

    著者: , , , , , - PLoS ONE 2015 被引用: 294

  22. Analysis of the clinical antibacterial and antituberculosis pipeline

    著者: , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 被引用: 219

  23. Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nizar Andria, Ami Neuberger, Anat Stern, Neta Petersiel, Marina Raines, Amir Karban, Leonard Leibovici, Dafna Yahav, Noa Eliakim‐Raz, Oren Zusman, Michal Elbaz, Heyam Atamna, Vered Daitch, Tanya Babich, Yehuda Carmeli, Amir Nutman, Amos Adler, Inbar Levi, George L. Daikos, Anna Skiada, Ioannis Pavleas, Anastasia Antoniadou, Antigoni Kotsaki, Emanuele Durante‐Mangoni, Roberto Andini, Domenico Iossa, Mariano Bernardo, Giusi Cavezza, Lorenzo Bertolino, Giuseppe Giuffrè, Roberto Giurazza, Susanna Cuccurullo, Maria Galdo, Patrizia Murino, Adriano Cristinziano, Antonio Corcione, Rosa Zampino, Pia Clara Pafundi - Clinical Infectious Diseases 2018 被引用: 126

  24. Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gilat Livni, Mical Paul, Menachem Gross, Matityahou Ormianer, Saima Aslam, Michele Ritter, Kenneth L. Urish, Ricardo M. La Hoz, Ameneh Khatami, Philip N Britton, Ruby C.Y. Lin, Jonathan R. Iredell, Aleksandra Petrović Fabijan, Stephanie Lynch, Pranita D. Tamma, Alexandra Yamshchikov, Emil Lesho, Megan M Morales, Alissa Werzen, Kapil Saharia - Med 2023 被引用: 53